Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

James H. Doroshow

Matched on ORCID iD 0000-0002-4463-1790; OpenAlex author ID A5041200743; NIH RePORTER profile ID 9692531. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 6)
Trials
0
Grants
1
Labs led
1
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 grant

Papers 7

  1. Exogenous DNA enhances DUOX2 expression and function in human pancreatic cancer cells by activating the cGAS-STING signaling pathway. Last author DOI 10.1016/j.freeradbiomed.2023.06.012↗
  2. Dexamethasone Inhibits Cytokine-Induced, DUOX2-Related VEGF-A Expression and DNA damage in Human Pancreatic Cancer Cells and Growth of Pancreatic Cancer Xenogr… Last author DOI 10.1101/2022.02.13.480277↗
  3. IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Canc… Last author DOI 10.4049/jimmunol.1800469↗
  4. Dual oxidase 2 and pancreatic adenocarcinoma: IFN-γ-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1α and … Last author DOI 10.18632/oncotarget.12032↗
  5. Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal ant… Co-author DOI 10.3892/ijo.2013.1821↗
  6. Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer c… Last author DOI 10.4049/jimmunol.1201725↗
  7. Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expr… Last author DOI 10.1074/jbc.m110.191031↗

Grants 1

  1. NADPH Oxidases as Novel Targets for Cancer Therapy ZIABC010677↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Krishnendu Roy · 7 shared papers, 2011–2023 · strength 0.53
  2. Yongzhong Wu · 6 shared papers, 2011–2023 · strength 0.49
  3. Mariam M. Konaté · 3 shared papers, 2019–2023 · strength 0.38
  4. Stephen L. Wang · 1 shared paper, 2023 · strength 0.16
  5. Yonghzong Wu · 1 shared paper, 2013 · strength 0.03
  6. Stephen M. Hewitt · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.